1 |
Low KC , Tergaonkar V (2013). Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochemical Sciences, 38, 426-34.
DOI
|
2 |
Mishra A, Kumar R, Tyagi A, et al (2015). Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer. Ecancermedicalscience, 9.
|
3 |
Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE (2014). Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials, 35, 3365-83.
DOI
|
4 |
Tyagi AK, Prasad S (2015). Targeting P53 Pathway by curcumin for cancer prevention and treatment. Cell Dev Biol, 4, 2.
|
5 |
Devassy JG, Nwachukwu ID, Jones PJ (2015). Curcumin and cancer: barriers to obtaining a health claim. Nutrition Rev, 64
|
6 |
Chung M-Y, Lim TG, Lee KW (2013). Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol, 19, 984.
DOI
|
7 |
Cildir G, Akincilar SC, Tergaonkar V (2013). Chronic adipose tissue inflammation: all immune cells on the stage. Trends Molecular Med, 19, 487-500.
DOI
|
8 |
Das L and Vinayak M (2015). Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 Signalling and Modulation of Inflammation in Prevention of Cancer.
|
9 |
Divya CS, Pillai MR (2006). Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Molecular carcinogenesis, 45, 320-32.
DOI
|
10 |
Donipati P, Sreeramulu SH (2015). In vitro anticancer activity of Curcuma longa against human breast cancer. Cell Line Mcf, 7.
|
11 |
Ferreira L, Arbab A, Jardim-Perassi B, et al (2015a). Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer. Anticancer Agents Med Chem, 15, 1285-96.
DOI
|
12 |
Ferreira LC, Arbab AS, Jardim-Perassi BV, (2015b). Abstract A02: Effect of curcumin on the tumor growth and angiogenesis of breast cancer. Cancer Res, 75, A02-A02.
|
13 |
Fiala M (2015). Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon- production: benefits of omega-3 with curcumin against cancer. Molecules, 20, 3020-6.
DOI
|
14 |
Park W, Amin AR, Chen ZG, Shin DM (2013). New perspectives of curcumin in cancer prevention. Cancer Prev Res, 6, 387-400.
DOI
|
15 |
Niu T, Tian Y, Cai Q, Ren Q, Wei L (2015). Red light combined with blue light irradiation regulates proliferation and apoptosis in skin keratinocytes in combination with low concentrations of curcumin. PloS One, 10, 138754.
|
16 |
Norris L, Karmokar A, Howells L, et al (2013). The role of cancer stem cells in the anti-carcinogenicity of curcumin. Mol Nutr Food Res, 57, 1630-7.
DOI
|
17 |
Nunez-Sanchez MA, , Romo-Vaquero M, et al (2015). Dietary phenolics against colorectal cancer-From promising preclinical results to poor translation into clinical trials: Pitfalls and future needs. Mol Nutr Food Res, 59, 1274-91.
DOI
|
18 |
Roux PP, Blenis J (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Molecular Biol Reviews, 68, 320-44.
DOI
|
19 |
Sareen R, Jain N, Pandit V (2013). Curcumin: A boon to colonic diseases. Current Drug Targets, 14, 1210-8.
DOI
|
20 |
Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V (2012). Multifaceted link between cancer and inflammation. Bioscience Reports, 32, 1-15.
DOI
|
21 |
Shehzad A, Lee J, Lee YS (2013). Curcumin in various cancers. Biofactors, 39, 56-68.
DOI
|
22 |
Sethi G, Tergaonkar V (2009). Potential pharmacological control of the NF- pathway. Trends Pharmacological Sci, 30, 313-21.
DOI
|
23 |
Shanmugam MK, Kannaiyan R, Sethi G (2011). Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer, 63, 161-73.
DOI
|
24 |
Shanmugam MK, Rane G, Kanchi MM, et al (2015). The multifaceted role of curcumin in cancer prevention and treatment. Molecules, 20, 2728-69.
DOI
|
25 |
Shanmugam MK, Sethi G (2013). Role of epigenetics in inflammation-associated diseases. Subcell Biochem, 61, 627-57.
|
26 |
Sharma S, Kulkarni SK, Chopra K (2006). Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 33, 940-5.
DOI
|
27 |
Siveen KS, Sikka S, Surana R, et al (2014). Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta - Reviews on Cancer, 1845, 136-54.
DOI
|
28 |
Soetikno V, Sari FR, Sukumaran V, et al (2013). Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. J Nutritional Biochem, 24, 796-802.
DOI
|
29 |
Subramaniam A, Shanmugam MK, Perumal E, et al (2013). Potential role of signal transducer and activator of transcription (STAT). 3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta -Reviews on Cancer, 1835, 46-60.
DOI
|
30 |
Sethi G, Sung B, Aggarwal BB (2008). Nuclear factor- activation: from bench to bedside. Exp Biol Med, 233, 21-31.
DOI
|
31 |
Yao Q, Lin M, Wang Y, et al (2015). Curcumin induces the apoptosis of A549 cells via oxidative stress and MAPK signaling pathways. Int J Molecular Med, 36, 1118-26.
DOI
|
32 |
Wu J, Tang Q, Zhao S, et al (2014). Extracellular signalregulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin. Int J Oncol, 45, 95-103.
DOI
|
33 |
Xi Y, Gao H, Callaghan MU, et al (2015). Induction of BCL2-interacting killer, BIK, is mediated for anti-cancer activity of curcumin in human head and neck squamous cell carcinoma cells. J Cancer, 6, 327.
DOI
|
34 |
Yallapu MM, Nagesh PKB, Jaggi M, Chauhan SC (2015). Therapeutic applications of curcumin nanoformulations. AAPS J 17, 1341-56.
DOI
|
35 |
Zlotogorski A, Dayan A, Dayan D, et al (2013). Nutraceuticals as new treatment approaches for oral cancer-I: curcumin. Oral Oncol, 49, 187-191.
DOI
|
36 |
Zong H, Wang F, Fan Q-X, Wang L-X (2012). Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NFkappa B signaling pathways. Molecular Biology Reports, 39, 4803-8.
DOI
|
37 |
Chen A, Xu J, Johnson A (2006). Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene, 25, 278-87.
DOI
|
38 |
Azmi L, Ojha SK, Rao CV (2015). Curcumin: boon for human beings. World J Pharmacy Pharmaceutical Sci, 4, 239-249.
|
39 |
Bimonte S, Barbieri A, Palma G, et al (2015). Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer. BioMed Res Int, 2015.
|
40 |
Chaturvedi M, Sung B, Yadav V, Kannappan R, Aggarwal B (2011). NF- addiction and its role in cancer:'one size does not fit all'. Oncogene, 30, 1615-30.
DOI
|
41 |
Kapakos G, Youreva V, Srivastava AK (2012). Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells. Canadian J Physiol Pharmacol, 90, 1277-85.
DOI
|
42 |
Gao W, Chan JY, Wei WI, Wong TS (2012). Anti-cancer effects of curcumin on head and neck cancers. Anticancer Agents Med Chem, 12, 1110-6.
DOI
|
43 |
Gee VM, Wong FS, Ramachandran L, et al (2014). Identification of novel peroxisome proliferator-activated receptor-gamma ( ). agonists using molecular modeling method. J Computer-Aided Molecular Design, 28, 1143-51.
DOI
|
44 |
Gupta SC, Patchva S, Aggarwal BB (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J, 15, 195-218.
DOI
|
45 |
Gupta SC, Prasad S, Kim JH, et al (2011). Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports, 28, 1937-55.
DOI
|
46 |
Huang T, Chen Z, Fang L (2013). Curcumin inhibits LPS-induced EMT through downregulation of NF- -Snail signaling in breast cancer cells. Oncol Reports, 29, 117-124.
DOI
|
47 |
Kolch W, Pitt A (2010). Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nature Reviews Cancer, 10, 618-29.
DOI
|
48 |
Lemmon MA, Schlessinger J (2010). Cell signaling by receptor tyrosine kinases. Cell, 141, 1117-34.
DOI
|
49 |
Li X, Chen S, Zhang B, et al (2012). In situ injectable nano-composite hydrogel composed of curcumin, N, O-carboxymethyl chitosan and oxidized alginate for wound healing application. Int J Pharmaceutics, 437, 110-9.
DOI
|
50 |
Li F, Sethi G (2010). Targeting transcription factor NF- to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta -Reviews on Cancer, 1805, 167-80.
DOI
|
51 |
Lopez-Bergami P, Lau E, Ronai Ze (2010). Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nature Review Cancer, 10, 65-76.
DOI
|